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A System Model fo r  Halothane Closed-Circuit 
Anesthesia
Structure Considerations and Performance Evaluation
P. M. Vermeulen, M.D.,* J. G. C. Lerou, M.D., Ph.D.,* R. Dirksen, M.D., Ph.D.,-\ 
L. H. D. J. Booij, M.D., Ph.D., F . R . C . A G. F, Borm, Ph.D.§
Background: Previously, the authors described a physiologic 
model for closed-circuit Inhalatlonal anesthesia. The basic 
version of this system model was clinically validated for iso- 
flurane. An extended version adopted nonpulmonary elimi­
nation causing a constant fraction of anesthetic to be irre­
versibly lost. This version improved the accuracy o f the model 
for enflurane. The model’s performance for other inhalational 
anesthetics that are not biochemically inert, such as halothane, 
remained to be evaluated.
Methods: The current study quantified the predictive per­
formance o f four versions of the model by comparison of the 
predicted and measured alveolar halothane concentration­
time profiles in  53 patients. Version A did not incorporate 
nonpulmonary elimination, whereas version D adopted a 
nonlinear hepatic nonpulmonary elimination following Mi- 
chaelis-Menten kinetics. A and D used fixed partition coeffi-
with an rntse of 19.6 ± 7.2%, a bias of 0.5 ± 15.9%, and a scatter 
of 13.2 ± 3-5% (mean ± SD).
Conclusions; The model incorporating nonpulmonary elim­
ination and age-adjusted partition coefficients (D') Is suffi­
ciently reliable and accurate to represent halothane closed- 
circuit anesthesia. This system model, with its various ver­
sions, is a valuable tool to predict the dynamics of isoflurane, 
enflurane, and halothane for clinical, educational, and re­
search purposes. (Key words: Age factors: solubility. Anes­
thetic techniques: closed-circuit. Anesthetics, volatile: halo­
thane. Biotransformation: drug. Computer, simulation: mod­
els. Equipment, circuits: closed. Measurement techniques: mass 
spectrometry. Pharmacokinetics: distribution; elimination; 
kinetics; physiologic model; uptake.)
PREVIOUSLY, we a for
dents. Their counterparts, A' and D', were formulated to ex- closed-circuit inhalation anesthesia to evaluate its pre-
amlne the Impact of age-adjusted partition coefficients on the 
accuracy of our model. Each concentration measured by mass 
spectrometry was compared to four predicted concentrations 
calculated by four computer simulations (one p er  version). 
For each patient, the authors calculated the root mean squared 
error ( rrnse; typical error size), bias (systematic component), 
and scatter o f the prediction errors.
Results: Fifty-three patients were anesthetized with 330 ml 
of liquid halothane via  426 bolus injections during more than 
6l h; 21,890 alveolar concentrations (average 0.6 vol%) were 
measured. Version D' showed the best overall performance
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dictive performance for the widely used volatile an­
esthetics.1 Using isoflurane as the anesthetic, we found 
close agreement between end-tidal isoflurane concen­
trations measured in our clinical study and those pre­
dicted by our basic system model.2 For enflurane, we 
demonstrated that the introduction of a nonpu lmonary 
route of elimination (NPE) into the model improved 
its clinical accuracy. In the absence of directly appli­
cable data for enflurane, we emulated its NPE by adopt­
ing the irreversible loss of a constant fraction of en- 
flurane from the arterial hepatic blood flow. *
Many studies reported an even greater NPE for halo­
thane than for enflurane. Moreover, a critical appraisal 
of the literature showed that (1) the NPE of halothane 
is better documented than that of enflurane, e.g. data 
are available on the nonlinear kinetics of halothane,4“7 
and (2) there exists an age-dependent variation in the 
solubility of inhalation anesthetics.8”10 However, to our 
current knowledge, there was no validated physiologic 
model to which all this information was supplied.
The primary objective of the current study was to 
quantify our model’s predictive performance for halo­
thane closed-circuit anesthesia. In addition, we ques-
Anesthesiology, V 83, No 3, Sep 1995
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tioned the impact on the model’s accuracy and thus vol%), and anesthesia using the liquid injection method 
on its clinical relevance of (1) the adoption of a non- was administered by one of us (P.M.V.). One bolus of 
linear NPE in this model and (2) the use of age-related liquid halothane 0.015 ml/kg (±0.1 ml) was injected
versus fixed partition coefficients. Therefore, four ver- after the start of closed-circuit conditions to rapidly
sions of our system model were formulated. One ver- attain the end-tidal halothane concentration desired in
sion (A) does not include NPE; another version (D) an individual patient. During maintenance, we admin-
accounts for a nonlinear NPE by adopting Michaelis- istered halothane bolus injections of 0.01 ml/kg. We
Menten kinetics in the liver compartment. These two did not use a rigid drug regimen but modified the halo-
versions use fixed partition coefficients, whereas their thane administration according to the patient’s re-
counterparts (versions A'and D') use age-related blood- sponse and/or the end-tidal halothane concentration
gas and tissue-blood partition coefficients. measured.
The system model is capable of predicting the time 
courses of the alveolar concentrations of a volatile an­
esthetic after the addition of increments of a mass of
Instru m en ta tion
The anesthetic equipment consisted of a Modulus CD
anesthetic into the closed-circuit system. Bolus injec- anesthesia system (Ohmeda, Madison, WI) with an in- 
tions of liquid halothane were administered into the tegrated ARKIVE automated anesthesia record-keeper
expiratory limb of the closed circuit, and the observed
were
(Ohmeda, Madison, WI, and DIATEK, San Diego, CA). 
The latter processed the signals provided by the in- 
with those predicted by the different versions of our struments integrated in the Modulus CD anesthesia sys- 
model. tem for monitoring patient’s vital signs. A standing bel-
M aterials and Methods
The methods have been described in detail earlier2,3 
and are summarized here with subsequent modifica­
tions and elaborations.
Patients and  Anesthetic Technique
Fifty-three consenting patients (ASA physical status 1
lows ventilator (Ohmeda 7850) was used. Leaks in the 
circuit were detected by plugging the Y-piece, pres­
surizing the breathing system to 4 kPa (40 cmH20 ), 
and observing the volume and pressure gauge; a gas 
leak up to 60 ml/min was accepted. A set of corrugated 
polyethylene tubings (Siemens Elema, Solna, Sweden) 
was used. Soda-lime was replaced at the beginning of 
each study day.
The fresh gas flow of oxygen and nitrous oxide was 
adjusted manually to maintain the inspiratory oxygen
and 2) scheduled for elective eye surgical procedures concentration between 30% and 40% and to keep the
were studied after approval of the Institutional Ethical 
and Research Committee. In the design of our study,
standing bellows at the same end-expiratory volume. 
We injected boluses of liquid halothane into the ex-
we did not include patients with prior halothane anes- piratory limb of the circuit, using a 2-ml glass syringe 
thesia or middle-aged females (40-60  yr old) who were and a homemade nickel-plated brass injection port.
also very obese (body mass index > 3 0  kg/m2) , because
features may introduce an in­
creased risk of halothane hepatotoxicity.11
Diazepam (5 -10  mg) and droperidol (2 .5-5  mg) 
were given orally 1 h before surgery. Anesthesia was 
induced with 0 .1 -0 .2  mg intravenous fentanyl, a dose 
of thiopental sufficient to obtund the eyelash reflex,
Immediate contact of the anesthetic agent with plastic 
tubing was avoided because of the corrosive properties 
of liquid halothane. Between successive procedures, 
the ventilator and anesthetic circuit were flushed with 
a high fresh gas flow of 100% 0 2 for 5 min.
Data acquisition and part of the instrumentation are 
illustrated in the upper half of figure 1. A respiratory
and 0.1 mg/kg vecuronium. After placement of a cuffed mass spectrometer (Centronic 200 MGA, CaSE, Biggin
endotracheal tube, the lungs of the patient were me­
chanically ventilated with a high fresh gas flow of ox-
Hill, England) continuously sampled gas at the Y-piece 
via a side-stream sampling port through a 30-m nylon
ygen and nitrous oxide in a 1:2 ratio for 5 min or until catheter with a 10-90% response time of 302 ms for
the end-tidal nitrogen concentration was less than 1 halothane.12 The mass spectrometer sample flow (mea-
vol%. Subsequently, the anesthetic system was closed, sured with a bubble flow meter) was 40 ml/min. Before
controlled ventilation was instituted (maintaining an using the mass spectrometer, we verified its calibration
end-tidal carbon dioxide concentration of 4 .0-4 .5  fo r  halothane with a calibration gas mixture containing
Anesthesiology, V 83, No 3, Sep 199*5
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step 1: producing the model input
An eight-channel chart recorder (Gould-Brush 481) 
running at 6 mm/min recorded the mass spectrometer 
output signals. The chart recorder and the mass spec­
trometer were located in a room next to the operating 
theater.
An AT personal computer system (640 kB RAM, 80287 
coprocessor, 30 Mb hard disk unit, and color VGA graph­
ics board, IBM, Portsmouth, United Kingdom) and a 12- 
bit analog-to-digital board (DAS-16, Keithley Metrabyte, 
Taunton, MA) processed the signals from the mass spec­
trometer at a sample rate of 10 Hz. The data acquisition 
software was developed with the aid of ASYST Version 
4.0 (Keithley Metrabyte). Online analysis of the respi­
ratory waveforms allowed the continuous monitoring of 
the actual inspiratory and end-expiratory concentrations 
in the operating room of nitrogen, oxygen, carbon diox­
ide, nitrous oxide, argon, and halothane. The trends of 
the inspiratory and end-expiratory concentrations of 
halothane and oxygen of the last 20 min were displayed 
continuously in the operating room. The last end-tidal 
halothane concentration per 10-s period was saved on the 
hard disk. We used an Intel 80486-based computer system 
for simulation purposes and further data processing.
predicted 
alveolar halothane 
concentrations
(1 data point per 10 s)
measured 
alveolar halothane
concentrations
(1 data point per 10 s)
The Model: Its Versions and Input 
The model we sought to validate was our physiologic 
model, which was developed with a special-purpose 
simulation language (TUTSIM Professional Version 7.0,
, The Netherlands).|| Fig-
rmse scatter
Meerman Automation, 
ure 2 schematically depicts the structure 
and the inset shows the size and mechanisms of NPE. 
Version A does not account for a route of NPE, and its 
structure is identical to the structure of version A in
the previous study for isoflurane, which assumed that
I;lg. 1. Flow diagram o f data acquisition and data processing.
The upper half o f the figure depicts the acquisition o f data.
There was a continuous online analysis and recording of the ,,
respiratory waveforms. One alveolar halothane concentration isoflurane’s NPE WilS Zero.“ In the current Study, version 
per 10 s was saved on the hard disk of the computer system. D was constructed to define a nonlinear NPE as a result
The necessary model input data were collected for each In­
dividual patient. The lower half of the figure Illustrates the 
three steps of data processing: (1) the anthropometric data 
and halothane dosage schedule were supplied to the model;
(2) computer simulation runs (four, one per model version) 
generated the predicted values; and (3) the predictive perfor­
mance measures of the four versions were calculated, rmse ~ 
root mean squared error.
0.98% halothane in 30.2% oxygen, 6.05% carbon 
dioxide, 30.1% nitrogen, balance gas nitrous oxide 
(L’Air Liquide, Antwerpen, Belgium), 
of variation of the mass spectrometer readings is 2%.
A list on paper is available on request.
of biotransformation obeying Michaelis-Menten kinet­
ics. To mimic this NPE, we implemented the data of 
various authors4-0 who demonstrated a concentration- 
dependent hepatic halothane metabolism. The equa­
tions used to calculate the fractions removed from the 
liver blood flow are presented in Appendix I.
Versions A and D use fixed partition coefficients ac­
cording to Lowe and Ernst.1-1 Versions A' and D' are the 
counterparts of versions A and D, respectively. Version 
A' and D' adopt blood-gas and tissue-blood partition 
coefficients that are functions of age according to the 
recent data of Lerman et and Malviya and Ler- 
man.10 Because they reported values for only live dif­
ferent ages, we had to interpolate for the intervening
Anesthesiology, V 83, No 3, Sep 1995
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Fig. 2. Schematic diagram of our 14-compartment physiologic 
model. (Inset) The various versions with special emphasis on 
nonpulmonary elimination (NPE). The fraction NPE on the 
ordinate is the fraction of the amount of anesthetic agent ir­
reversibly lost from the hepatic blood flow. The arterial halo- 
thane concentration Is on the abscissa. Version A has the 
identical structure of A in the previous validation study for 
isoflurane and assumes that NPE is zero. Version C has been 
used only in the enflurane validation study and uses a constant 
fraction of NPE. Version D incorporates a nonlinear NPE fol­
lowing Michaelis-Menten kinetics. Versions A, C, and D use 
fixed partition coefficients, whereas A' and D' adopt age-related 
partition coefficients. (c)v - (central) venous; a = arterial.
input was generated by means of an ASYST application 
program. The amount of liquid halothane per injection 
was converted into milliliters of vapor (1 ml of liquid 
halothane yields 240 ml of vapor at 37°C) and supplied 
to the model as if the vapor were added to the anesthetic 
system over a 60-s interval (the time needed for con­
version of liquid to vapor). Throughout step two, our 
model generated the predicted time courses of the al­
veolar halothane concentrations by running the TUTSIM 
simulation program. Four simulation runs were per­
formed for each patient: one per version. In the final 
step, by importing the predicted and measured data 
into another ASYST application program, the predictive 
performance measures were calculated for further 
analysis.
Predictive Performance Measures
The measures that serve to determine the predictive 
performance of our model were described and dis­
cussed in previously published studies.2,3 Detailed in­
formation is given in Appendix II, and a summary fol­
lows .
The prediction error (pe) is the difference between 
a predicted and a measured value of the halothane con­
centration, expressed as a percentage of the measured 
value. The pe  and the squared prediction error (pe2) 
are calculated for each time period of 10 s. These two 
quantities are manipulated to provide the predictive 
performance measures, which are calculated first per 
patient and then for the group.
The bias, i.e., the average of the prediction errors for 
an individual patient, is a measure of the systematic
Table 1. Halothane Partition Coefficients
Version* 
A/D (All 
Ages)
Version A'/D't (yr)
0 5 35 60 80
ages of individual patients. Where no age-adjusted val­
ues were available, the data reported by Lowe and Ernst 
were used. The drug-specific data for halothane incor- 
porated in the model are listed in table 1. . Ac0Md|ng t0 Lowe and Ernst „
Data processing was the three-step process shown ill |  According to Lerman et a/.8,0 and Malviya and Lerman10; where no age-adjusted 
the lower half of figure X. During Step one, the model values were available, the data reported by Lowe and Ernst were used.
Blood-gas 2.4 2.14 2.39 2.65 2.51 2.41
Tissue-blood
Lung 2.0
Kidney 1.5
Heart 2.5 2.06 1.42 2.17 2.06
Brain 2.3 1.54 2.03 1.92 2.02
Liver 2.5 2.12 2.15 2.84 2.80
Muscle 1.3 1.25 1.44 2.31 2.90
Connective 1.2
Adipose 75.0 60.62 66.56 67.34
Anesthesiology, V 83, No 3, Sep 1995
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Table 2. Demographic Characteristics
Mean ±  SD Minimum Maximum
Age (yr) 47.4 ± 15.5 21.0 72.0
Weight (kg) 76.8 di 13.7 52.0 110.0
Height (m) 1.76 ± 0.09 1.55 1.96
Body mass index* (kg • m“2) 24.6 3.7 17.8 35.4
53 patients provided 21,890 samples of intraoperative 
data. They were anesthetized with 330 ml of liquid 
halothane during more than 61 h, not including the
additional hours closed-circuit
N = 53.
* Patients with a body mass index s20 kg ■ nrf 2 can be considered slender; 
patients with a body mass index s25 kg • m~z can be designated obese.
conditions; details on the closed-circuit conditions are 
recorded in table 3.
Figures 3 and 4 illustrate the measured and pre 
concentrations as a function of time in two re
component of error. The bias can be positive or neg­
ative, indicating overprediction or underprediction, 
respectively.
The mean squared error (mse) is the average of the 
squared prediction errors, rmse is defined as '\fmse and 
is a measure of the typical size of the error for an in-
tative patients. Figure 3 provides a visual impression 
of the quality of the predictions achieved with version 
D' for the longest anesthetic procedure. Figure 4 shows 
the predictions generated by versions A and D' for the 
average patient.
Predictive Performance o f  the Versions
Figures 5 and 6 are two dot diagrams showing the
distribution of the individual biases and scatters along 
dividual because it is not influenced by the sign of the with their means and standard deviations for the various
prediction errors, rm se  can be formulated as being 
composed of bias and scatter.
The scatter is a measure of the variability of the pre­
diction errors around their mean (bias) for a particular 
patient. The relationship between rmse, bias, and scat-
ter is
rmse Vbias2 + scatter2.
The numeric average of all the rmses— one per pa­
tient— yields the “group rmse."  The “group bias” and 
“group scatter” are the means of the individual biases 
and scatters, respectively. The measures are calculated
Statistical Analysis
The Friedman two-way analysis of variance was used
versions. Figure 5 shows that version D' performs better 
than the other versions as to the number of patients 
with a negative versus positive bias. A positive group 
bias is a measure of systematic overprediction, whereas 
a negative group bias indicates a systematic underpre­
diction. Note also the normal distribution of the data 
for the four versions. Figure 6 illustrates that the range 
of the individual scatters is smallest for version D'.
Table 4 lists the group rmses, biases, and scatters. 
The magnitude of the biases of all of the versions was 
smaller than their scatters. This means that the average, 
typical size of the prediction error mainly was due to 
the scatter rather than to the systematic component.
Figure 7 summarizes and displays the results for the 
four versions. Each patient is represented by one dot
Table 3< Details on the Duration of Closed-circuit 
Conditions, the Number of Data Points, and the
Administration of Liquid Halothane into the Closed i
to compare the predictive performances of the four on each of the four X-Y plots. The iso-rmse lines allow 
versions. If the Friedman analysis revealed a difference, 
post hoc analysis using sign tests for paired data was 
done.
We used binary logistic regression to study the po­
tential influence of gender, age, body mass index 
(weight/height2), duration of closed-circuit anesthesia, 
and the number of injections per hour on each of two 
response variables: bias and scatter of the prediction 
errors.
The criterion for rejection of the null hypothesis was 
P < 0 . 0 5  (two-sided).
Results
Thirty-four males and 19 females participated in this 
study; their demographic data are listed in table 2 . The n = 53.
Mean i. SD Minimum Maximum Total
Duration (min) 69.2 ± 25.7 35.0 141.0 3,666
Number of data points 413 ± 154 208 844 21,890
Number of injections 8 ± 2.5 4 16 426
Number of injections per 7.1 ± 1.03 5.1 9.4
hour
Volume of liquid halothane 6.2 ± 2.1 2.5 12.2 329.9
(ml)
Average measured end- 0.63 ± 0.11 0.40 0.92
tidal halothane
concentration (vo!%)
Anesthesiology, V 83, No 3, Sep 1995
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Fig. 3- (/l) Measured and predicted alveolar halothane concen­
trations obtained in the longest case. A 28-yr-old patient 
(weight 75 kg, height 1.90 m) was adequately anesthetized 
with 12 bolus injections o f liquid halothane (total 9-55 ml) 
into the closed-circuit system over 141 min. (Z?) Profile o f the 
predictive performance for version D'. The rmse, bias, and 
scatter for this patient were 20.91%, 12.57%, and 16.71%, re­
spectively.
ers. This means that the following rank order exists for 
the scatters: A > D > A' >  D'.
A potential influence of the duration of closed-circuit 
anesthesia on the bias of versions D and D' was found. 
It corroborates the trend toward overprediction during 
the longer anesthetic procedures, as illustrated in figure 
3. The other explanatory variables were not significant.
Discussion
The primary goal of our study was to extend our 
physiologic model for the anesthetic agent halothane, 
which is not biochemically inert, and to quantify its 
predictive performance. We adapted the model’s 
structural features, formulating four versions of this 
model, by the incorporation of more recent physico­
chemical data retrieved from the literature. The main 
point of originality in the design of these new versions 
lies in the use of age-related partition coefficients and 
a route of nonlinear hepatic NPE following Michaelis- 
Menten kinetics. We evaluated the impact of these dif­
ferent inputs of information on the accuracy of our 
system model without inclining a priori to one of these 
versions.
«
It is of critical importance to validate a model, be­
cause far-reaching conclusions can be drawn from 
model behavior. Standards to judge the validity of a 
physiologic model for volatile anesthetics hitherto have 
not been defined explicitly. Also, in our previous work, 
we did not substantiate why the reported error size 
could be qualified as acceptable.2,3 By analogy with
work in other areas of research, M.IS we need to propose
more precise rules to determine whether a physiologic 
model for inhaled anesthetic agents has acceptable ac­
curacy.
First, a valid operational model should not under- 
predict or overpredict reality in a systematic way. Al- 
a visual impression of the overall performance of the though it is reasonable to expect a certain degree of
model and its versions. A rank order exists for the num- bias for each patient, the group bias should approxi-
ber of patients having an rmse > 30%: A > D > A' > D' mate zero. For example, a model that suffers from a
(13, 10, 7, and 5 out of 53 patients, respectively). systematic underprediction would teach the user in a
The Friedman analysis revealed that there is a differ- training environment to administer more drug than the
ence between the four versions for the group rmses (P average patient would need to attain a desired end-
< 0.001). The sign tests for paired data showed that tidal concentration. We propose that the magnitude of
version D' performs better and that version A performs the group bias should not exceed 10% because it can
worse than the three other versions. A difference also be defended that such a degree of bias allows prediction
is found for the group biases-, version A differs from A', within limits to which inhaled anesthetic agents can 
D, and D'. The null hypothesis was rejected for the be used safely.
group scatters. Table 4 shows that the group scatter for 
each of the versions differs from those of the three oth-
Second, if the group bias approximates zero, the typ­
ical error size should be acceptable for a majority of
Anesthesiology, V 83, No 3, Sep 1995
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Fig. 5. Dot diagram showing the distribution of the individual 
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viations for the four versions. Version A shows a systematic 
overprediction (group bias 13*57%). Version D' has a more 
equal distribution of the number of negative versus positive 
biases and produces a clinically negligible group bias (0.48%). 
The values for the individual biases were rounded to whole 
numbers to avoid superposition of dots. Note that the dots
represent four times 53 paired observations. group bias.
the rmse is less than 30% for an even greater proportion 
of the subjects (preferably 90% or more). This may 
only prove possible if some knowledge on an individual 
patient can be supplied to the model.
Although a physiologic model can be designated valid 
on the basis of the two quantitative requirements given 
above, some discussion remains when its structure fails 
to reflect some well established data from the literature.
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the patients. An acceptable error size must be defined 
on the basis of the biologic variability found in a general 
human population. The variability in uptake of inhaled 
anesthetics ranges from 10% to 33% (coefficient Of Fig. 6. Distribution of the individual scatters (n =  53) for the 
variation, i.e., one standard deviation divided by the 
mean times 100 ).16-21 On these grounds, we propose 
that the typical error size of a physiologic model with 
zero group bias is acceptable if the rmse  of at least 
68% of the subjects studied is <30%. From the point 
of view of the user of a model, one would wish that
four versions as well as the group scatters and their standard 
deviations. Statistical significant difference between the ver­
sions results in the rank order A > D > A' > D'. The incorpo­
ration of age-adjusted partition coefficients (versions A' and 
D') lowers the scatters, i.e. improves the accuracy of the model. 
The values for the individual scatters were rounded to whole 
numbers to avoid superposition of dots. Dots represent four
times 53 paired observations. group scatter.
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Table 4. Predictive Performance o f the Model Versions
Version
________________________________A________ ______________ A ______________________ D_______________________U __________________ P * ^
rmse (%) 25.28 ± 11.08f 21.11 ± 8.60 22.08 ± 8.59 19.59 ± 7.20f <0.001
Bias (%) 13.57 ± 17.35* 5.70 ± 16.67 7.99 ± 16.44 0.48 ± 15.92 <0.01
Scatter (%) 15.92 ± 5.20f 13.96 ± 4.24f 14.59 ± 4.23f 13.18 ± 3.49f <0.001
Values are mean ±  SD.
rmse = root mean squared error.
* Friedman two-way analysis of variance.
t  Significantly different from all other versions (sign tests for paired data), 
t  Statistically significant difference versus versions A', D, and D' (sign tests for paired data).
The goal of physiologic modelling is to put into overt However, a physiologic model without NPE for halo-
form the a priori knowledge about a system. In a teach- thane, such as version A', conflicts with reality. Cowles 
ing situation, a model for the uptake, distribution, and et al.22 reported a systematic discrepancy (6.4% in
elimination of halothane without NPE would clash with terms of their “differences between areas” ) between
the information on halothane bio transformation. In the the values computed by their model and those mea-
case of model versions with similar accuracies but dif- sured in dogs. They suggested that a model that ac-
ferent structures, we therefore propose to select the counts for the loss of halothane by metabolism might
model version with the structure incorporating the improve accuracy. The difference between version A'
greatest part of available data. and D' is in accordance with their suggestion as well 
as with the observations that the NPE of halothane is a 
real but not a major determinant of the end-tidal con-Major Findings
The principal finding of this study is that only versions centrations during anesthesia.
A', D, and D' match our quantitative criteria outlined Based on the combined results (table 4) for the rmses,
above and are considered valid (fig. 7 and table 4 ). biases, and scatters, we conclude that D' performs better
The results indicate that these three versions only than A' and D. The structure of D' also reflects the well
slightly overpredict reality. Version D' produced a clin- documented NPE of halothane. Therefore, we prefer
ically negligible group bias of 0.48 ± 15.92%. Version 
D' also had an acceptable degree of accuracy because 
the rmse was less than 30% for 48 of 53 patients, i.e., 
91% of the subjects studied. A rmse < 20% was found
to use version D' for further work with halothane.
Nonpulmonary Elim ination
Although version D' closely predicts the alveolar con-
for 32 patients, i.e., 60% of the population. The right centration of halothane, our results do not prove that
lower quadrant of figure 7 visualizes these findings.
The observations are normally distributed across the 
zero bias line and centralize around the point of ideal 
performance in the semicircular area where the rmse is to be conceived and completed.
its structure is absolutely correct. One of the difficulties 
with physiologic models lies in obtaining the necessary 
quantification data,23 especially if a model for humans
is <30%. The latter error size implies any combination 
of bias and scatter, for example 0 and 30%, 21 and 
21%, or 30 and 0%.
All hydrocarbon inhalation anesthetics undergo b 
transformation, and small quantities leave the body i 
changed via nonpulmonary excretory pathways21-30 or
In comparison, version A' gave a group bias of 5.70 the ventilator or closed-circuit system during anes-
± 16.67%. The distribution of patients with a negative thesia.31-35 Mass balance studies do not discriminate
versus positive bias as shown in figures 5 and 7 rep- between the sources of anesthetic loss-. They measure
resents the slight systematic overprediction of this ver- the total irreversible anesthetic loss. As such, these
sion. A rmse less than 30% or 20% was found for 46 studies seemed useful for an all-embracinc formulation
or 31 patients, respectively, i.e., 87% or 58% of the of NPE with only one parameter, e.g., a fixed extraction 
population. These figures are little less than for D' and ratio. Unfortunately, there is a large variability in the 
thus suggest that our basic system model is robust. experimental results: a range of “anesthetic loss” as
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Fig. 7. Comparison o f  predictive performance measures obtained for model versions A, A', D, and D' in 53 patients. The individual 
scatters of the patients are plotted versus their Individual biases for the four versions. The triangles and the thick lines on the 
abscissas and the ordinates represent the group biases (±SD) and scatters (±SD), respectively. The group biases indicate that 
all versions suffer from overprediction, with A taking the worst position. Ideally, all observations on one version would coincide 
with the star representing the point o f ideal performance (root mean squared error ( rmse) = 0%). The semicircles are the iso- 
rmse-lines from  10% to 50%. The distance between the star and a dot is the rmse representing the typical error size for an 
individual patient. The left upper plot visualizes the mathematical relationship between the rmse, bias, and scatter (Appendix 
II, equation A5). The rmse is the hypotenuse of a right-angled triangle o f which the scatter and the bias are the opposite and 
the adjacent, respectively. The adoption of a nonlinear nonpulmonary elimination (D versus A) reduces both the biases and 
the scatters. The incorporation of age-adjusted partition coefficients (A' versus A and D' versus D) reduces the rmse,s. The plot 
for D' shows that 91% of the patients are found in the semicircular area where the rmse Is <30%.
broad as 50-80% has been reported, 
we refrained from using a fixed extraction ratio. In ad­
dition, adopting a fixed extraction ratio would have 
patently conflicted with the studies confirming nonlin­
ear kinetics.4-7,28 Many studies in humans, including 
the numerous toxicity investigations and case reports 
on halothane hepatitis, have shown halothane bio­
transformation. Most of these studies focused on the 
formation and measurement of metabolites, and all re­
ports agree on the fact that the liver is the primary site
of the NPE of halothane. However, because halothane 
metabolism is concentration-dependent, the results of 
metabolic and uptake studies at a single concentration 
may not apply at another.
Sawyer et al. 1 demonstrated in miniature swine that 
a greater fraction of the halothane delivered to the liver 
disappeared at lower concentration. They defined the 
fraction removed as equal with halothane metabolism.
and Holaday6 formulated a mathematical
model for this nonlinear kinetics, approximating the
Anesthesiology, V 83, No 3, Sep 1995
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experimental results published by Sawyer et al. (Ap­
pendix I ) . Other studies confirmed this concentration-
coefficients on our model’s accuracy. The analysis of 
the scatters of the four versions demonstrated that the
dependent biotransformation of halothane in hu- incorporation into the system model of age-related par- 
mans.40 '“ Calahan et al.,42 who estimated the kinetic tition coefficients significantly improved the overall
constants that characterize the metabolism of halothane 
in humans, assumed that the clearance of halothane is 
a combination of linear clearance to depots and satu­
rable metabolism attributable to a Michaelis-Menten 
process. However, we were not able to extract the nec­
essary data from their report. Eventually, we applied
(fig
Reservations
The limitations of the current study lead to our res­
ervations. The model should not be used without val­
idation for children or infants and other volatile an-
the equations from the nonlinear model developed by esthetic agents such as desflurane or sevoflurane. The
Feingold and Holaday. Thus their work was the key in trend toward overprediction (fig. 3B), as corroborated
versions D and D' of our system model to unlocking by the influence of the anesthesia time on the predictive
the door between the conception and the completion performance, must prevent us from using the model
of a workable model featuring nonlinear kinetics. We for long anesthetic procedures. The model includes
thereby recognize that extrahepatic elimination of tissue groups with long time constants, e.g., adipose
halothane and clearances to depots were ignored and tissue and connective tissue. These groups do not sig-
that the results from animal studies were implemented. 
This evokes the inevitable question about the influence
nificantly contribute to uptake during the first hour of 
anesthesia. Errors in the parameters defining the time
of species on the reported size and mechanism of the constants (volume, perfusion, tissue-blood coefficients) 
NPE of an inhaled anesthetic. However, we must rec- may contribute to the trend (fig. 3); this requires fur- 
ognize that, even in the same species, a large inter- and ther research. The natural individual variability and the
intraindividual variability exists. A study in twins dem- possible influence of coadministration of other anes-
onstrated an important genetic predisposition in the thetics that may result in changes in drug disposition 
biotransformation of drugs, because identical twins must prevent us from totally relying on model predic-
showed a 10% but fraternal twins a 30% range in halo­
thane metabolism.'13
tions.
Solubility
The quality of the predictions of a physiologic model
From this study, we conclude that our system model, 
although using simplifying assumptions, sufficiently 
represents the clinical reality of halothane closed-cir- 
cuit anesthesia. The choice to apply version D' is in
relies on the validity of the data used. A reliable sim- accordance with the many reports on halothane bio-
ulation of the pharmacokinetics of inhalational anes- transformation, suggesting that a nonlinear NPE is an
thetics therefore depends, inter alia, on well chosen indispensable part of a physiologic model for the up­
values for the partition coefficients. This becomes es- take, distribution, and elimination of halothane. The 
pecially important at the higher anesthetic concentra- new version, D', of this system model combines the 
tions used in clinical practice, when metabolism plays following features: It does not assume a zero circulation
a smaller role in the rate at which elimination occurs, time, and it uses age-related partition coefficients, in-
thereby permitting solubility to play a more important corporates nonlinear NPE, and is capable of predicting 
role.“  In versions A and D, we used the data of Lowe the alveolar concentration of anesthetic after bolus in­
jection of halothane into the closed circuit. This vali­
dated physiologic model provides a valuable tool to be 
used for a variety of so called “what happens if” scen­
arios— with the necessary reservations— for clinical,
and Ernst, who applied fixed partition coefficients in 
agreement with those mentioned by Steward et al.44 in 
their review, to be “ the most likely values.” However, 
age-related changes occur in the constituents (water, 
protein, and lipid concentration) of human tissues, and teaching, economical, ecologic, and research purposes.
the partition coefficients thus may differ with aging. 
Because Lerman et al.8■9 and Malviya and Lerman10 re­
ported such an effect of age on both the blood-gas and 
tissue-blood partition coefficients of inhalation anes­
thetics, two different versions A' and D' were created
Appendixes
I: Nonlinear Nonpulm onary Elimination
We refer to our previous study1 for a complete mathematical
to evaluate the impact of the use of age-related partition formulation of the original system model, which does not account
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for NPE and is designated version A. In this Appendix, we describe 
the modifications of version A that were necessary to construct 
version D.
NPE in version D was mimicked by the irreversible loss of a variable 
fraction of the anesthetic agent present in the blood flowing to the 
liver (fig. 2, inset). Accordingly, the rate of change of the concen­
tration of anesthetic agent in the venous blood draining the liver is 
given by
clCYumt Qliver
dt V lIv i 'r  X XT/ii (C'a( l  -/ftl-a) ~  <MW),
where Qiiwr is the hepatic blood flow, VUvcr is the volume of the liver, 
X-,yH is the liver/blood partition coefficient, Ca is the fractional con­
centration of agent in blood leaving the arterial blood pool, and f Nm 
is the fraction of the amount of anesthetic agent irreversibly lost from 
the hepatic blood flow.
We calculated the value of / NPI! from the equations reported by 
Feingold and Holaday6 (table 5). These authors described a nonlinear 
model of halothane biotransformation featuring Michaelis-Menten 
kinetics in the liver. Thus Pi: is inversely related to the hepatic 
arterial concentration. Therefore, they used an approximation of the 
experimental results of Sawyer et al.,4 who studied miniature swine 
weighing 35-45 kg. After conversion of the different units used in 
the two papers, the “ fractions removed” from both papers are vi­
sualized in figure Al. There is close agreement between the exper­
imental results of Sawyer et al. and the approximation by Feingold 
and Holaday.
w * *  l i f t
* 1 ^  
t *  y -  © si
o
CM
«
o
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« 
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Per cent alveolar halothane concentration
Fig. A l. Comparison o f the fractions of halothane removed 
from the hepatic blood flow as reported in two studies. This 
figure is based on a figure from the study of Sawyer et al.4 It 
shows their experimental results obtained in miniature swine 
(data expressed as mean and SEM). Alveolar concentrations 
below 0.0026% result in a nearly complete hepatic extraction 
o f halothane. However, the fraction removed decreases as the 
percentage alveolar halothane Increases. Feingold and 
Holaday6 used the equations listed in table 5 to approximate 
the findings of Sawyer e t al. The fractions removed are similar 
in both studies, especially between 1.6% and 0.01% alveolar 
halothane. This range was used in our clinical study. The 
equations o f Feingold and Holaday were incorporated in ver­
sions D and D' o f our model.
II: Predictive Performance Measures
The predictive performance of our physiologic model for volatile 
anesthetics was determined by the following measures.
The prediction error (p e ) , expressed as a percentage, was calcu­
lated for each pair of predicted and measured values as
p e
CA,f) CA , m
c X 100, (Al)Atm
where CA ], is the predicted alveolar concentration of halothane, and 
C\M is the measured alveolar concentration. A negative pe  implies 
that the predicted value u'nderpredicts the measured value, whereas 
a positive pe indicates that the predicted value overpredicts the mea­
sured value. The prediction errors were calculated for each period 
of 10 s for the separate versions.
Table 5. Equations for fNPE*
fNPE
>10 0
10 to 10"1 -0.010 log C f + 0.010
10~1 to 10~5 -0.195 log Cf -  0.175
10~6 to 10~° -0.050 log Cf + 0.550
<10~B 1.0
* According to Feingold and Holaday.8
W e = the fraction of the amount of anesthetic agent that is irreversibly lost 
from the hepatic blood flow; C* the arterial concentration of anesthetic agent 
expressed as mmol/100 ml.
The bias or mean prediction error (me) for each patient was given
by
1 n
me n (A2)
where n is the number of measurements per patient, and pt\ is the 
prediction error. The numeric average of all the biases— one per 
patient— yields the “group bias.” The bias possesses a direction 
(given by the plus or minus sign) and a magnitude (the value without 
the sign). The bias for each patient is influenced by the negative or 
positive sign of the prediction error, and thus does not provide in­
formation about the typical size of the prediction error if there are 
both under- and overpredictions in an individual patient. The influ­
ence of the sign can be avoided by defining a measure based on 
squared errors. Therefore, we first consider the mean squared pre­
diction error (mse), given by
1
mse
ri
,1^ ' ^
n pe?.4
The root mean squared prediction error (rmse), given by rinse, 
is a measure of the typical size of the prediction error for each in­
dividual patient. The numeric average of nil the rmses yields the 
group rmse. The mse can be decomposed into two terms:
1 n
mse = me n me) (A4 )
The square root of the first term in equation A4 is recognized as 
the magnitude of the individual bias defined in equation A2, providing
Anesthesiology, V 83, No 3, Sep 1995
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direct information on the magnitude of the systematic component 
of the prediction error for each individual patient.
12. Lerou JGC, van Egmond J, Beneken Kolmer HH: Evaluation of 
long sampling tubes for remote monitoring by mass spectrometry. J
The second term in equation A4 is a measure of the variability of Clin Monit 6:39-52, 1990
the prediction errors (pe i) around their mean (me). We used the 
second term’s square root to express the scatter of the pes for an 
individual patient. Calculating the numeric average of the 53 scatters 
(one per patient) represents the “group scatter.”
13. Lowe HJ, Ernst EA: The Quantitative Practice of Anesthesia. 
Baltimore, Williams & Wilkins, 1981
14. Glass PSA, Jacobs JR, Smith LR, Ginsberg B, Quill TJ, Bai SA, 
Reves JG: Pharmacokinetic model-driven infusion of fentanyl: As-
Combining the definition of rmse and equation A4 yields the re- sessment of accuracy. A n e s t h e s i o l o g y  73:1082-1090, 1990
latio.nsh.ip between rmse, bias, and scatter. This can be expressed as
liquations A2-A4 show that we do not include the three first data 
points, i.e., the first 30 s of observations, for each patient in the 
measure. Reasons for this were discussed elsewhere.2 Our predictive 
measures are based on the squared prediction errors, thus giving 
much weight to the differences between the predicted and observed 
values. The drawback of this approach (squaring the differences) is 
that the brief and clinically unimportant differences between model 
and reality during the first 30 s of the comparisons are also given 
much weight. Omitting the first three data points for each patient,
i.e., 159 of 21,890 data points, does not violate but rather augments 
the value of comparison between prediction and reality for clinical 
purposes.
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